<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Glycemic control prevents diabetic neuropathy</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Glycemic control prevents diabetic neuropathy</h1>
<div class="graphic"><div class="figure"><div class="ttl">Glycemic control prevents diabetic neuropathy</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Incidence of the development of clinically evident diabetic neuropathy at 5 years in patients with type 1 diabetes treated with conventional or intensive insulin therapy. Glycemic control was beneficial in both the primary prevention (no retinopathy) and secondary intervention (background retinopathy) cohorts. Patients with confirmed clinical neuropathy at baseline were excluded from the study. This comprised 3.5 percent of patients in the primary prevention cohort and 9.4 percent in the secondary intervention cohort.</div><div class="graphic_reference">Data from The Diabetes Control and Complications Research Group, N Engl J Med 1993; 329:977.</div><div id="graphicVersion">Graphic 70914 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
